DCF — HIGH POINT MEDICAL CENTER
Enterprise Value: $-72.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-72.3M
Enterprise Value
$-33.5M
PV of Cash Flows
$-38.8M
PV of Terminal Value
$-62.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $418.3M | $3.2M | 1.0% | $-14.5M | $-13.2M |
| Year 2 | $430.8M | $7.6M | 2.0% | $-10.6M | $-8.8M |
| Year 3 | $443.8M | $12.3M | 3.0% | $-6.8M | $-5.1M |
| Year 4 | $457.1M | $14.9M | 3.0% | $-5.3M | $-3.6M |
| Year 5 | $470.8M | $16.6M | 4.0% | $-4.6M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-72.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$406.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0026634533348163236
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5